Evidence map›Paper›PMID 10050881›Full record

ArticleOncogene1999

Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma.

I Desbaillets, A C Diserens, N de Tribolet, M F Hamou, E G Van Meir

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. ING4 is negatively correlated with microvessel density in colon cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2012
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Biology of angiogenesis and invasion in glioma.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2009
    Review
  18. Article
  19. The emerging role of anti-angiogenic therapy for malignant glioma.Current treatment options in oncology · 2008
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

I DesbailletsNeurosurgery Department, University Hospital (CHUV), Lausanne, Switzerland.
A C Diserens
N de Tribolet
M F Hamou
E G Van Meir
Emory University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxygen deprivation is an important biological feature of tumor growth. We previously showed that in glioma, anoxia increases expression of IL-8, a chemokine and angiogenic factor. Here, we analysed for the first time the biochemical mechanisms inducing the IL-8 gene upon anoxia in glioma cells, and showed that they differ from those inducing the VEGF gene. Both genes are induced in biologically and genetically heterogenous glioblastoma cell lines (LN-229, LN-Z308, U87MG, T98G), whereas, in gliosarcoma cells (D247MG), only the VEGF gene is induced. The kinetics of IL-8 and VEGF mRNA inductions differ in these cells and reoxygenation experiments showed that the induction is due to the anoxic stress per se. Furthermore, in LN-229 and LN-Z308 cell lines actinomycin D, DRB and nuclear run-on experiments showed that anoxia stimulates increased transcription of both genes. Electromobility shift assays show increased protein binding to the AP-1 site on the IL-8 promoter following anoxia treatment. Finally, in situ hybridization on glioblastoma sections shows that the in vivo expression patterns of IL-8 and VEGF genes overlap, but are not identical. Since intratumoral augmentation of IL-8 and VEGF secretion, following microenvironmental decreases in oxygen pressure, may promote angiogenesis, further definition of these pathways is essential to appropriately target them for antitumoral therapy.

Indexed as

AnimalsCell HypoxiaCobaltDactinomycinDichlororibofuranosylbenzimidazoleEndothelial Growth FactorsGene Expression RegulationGlioblastomaHumansInterleukin-8LymphokinesMiceNucleic Acid Synthesis InhibitorsOxidation-ReductionOxygenResponse ElementsCobaltDactinomycinDichlororibofuranosylbenzimidazoleEndothelial Growth FactorsInterleukin-8LymphokinesNucleic Acid Synthesis InhibitorsOxygenRNA, MessengerTranscription Factor AP-1Vascular Endothelial Growth Factor AVascular Endothelial Growth Factors

Identifiers

PMID10050881
OpenAlexW2052804176

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.